首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1798192

全球病理學設備市場

Pathology Devices

出版日期: 2025年08月26日 | 出版商:

Global Industry Analysts, Inc. | 英文 379 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球病理設備市場規模將達 81 億美元

全球病理學設備市場規模預計在2024年為60億美元，預計到2030年將達到81億美元，在分析期內（2024-2030年）的複合年成長率為5.1%。臨床化學技術是本報告分析的細分市場之一，預計其複合年成長率為6.0%，到分析期結束時規模將達到33億美元。免疫檢測技術領域在分析期間的複合年成長率預計為5.7%。

美國市場規模估計為 16 億美元，中國市場預期複合年成長率為 9.3%

美國病理設備市場規模預計2024年達到16億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到17億美元，在2024-2030年的分析期間內，複合年成長率為9.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.1%和4.0%。在歐洲，預計德國市場的複合年成長率為3.0%。

全球病理學設備市場—主要趨勢與促進因素摘要

病理學儀器如何發展以滿足精準診斷的需求？

病理學儀器處於醫學診斷生態系統的前沿，是疾病檢測、分類和治療監測的支柱。精準醫療、微創診斷和早期疾病識別的轉變正在推動一系列病理學儀器的創新，包括組織病理學儀器、細胞學系統、免疫組織化學平台、數位病理掃描儀和自動切片處理器。這些工具在實現高通量、高重現性和高分析靈敏度的測試工作流程方面發揮著至關重要的作用。

由於組織病理學仍然是癌症診斷和分期的黃金標準，對自動化組織處理器、切片機、包埋中心和染色系統的需求比以往任何時候都更重要。液基細胞學 (LBC) 系統和自動化玻片製備設備等細胞學設備在癌症篩檢計畫中越來越受歡迎，尤其是在子宮頸癌和呼吸道癌的篩檢中。同時，免疫組織化學 (IHC) 已被廣泛用於腫瘤學中的生物標記檢測，而基於抗體的染色系統正被整合到實驗室自動化流程中，以確保一致性和擴充性。

此外，數位病理學的興起正在將基於玻片的診斷從類比方式轉變為以影像為中心的平台。全玻片成像 (WSI) 設備將傳統的玻片轉換為高解析度的數位格式，然後由人工智慧軟體進行分析，以確定細胞形態、腫瘤分級和異常檢測。這種數位化促進了病理學家之間的遠距協作，減少了觀察者之間的差異，並支持醫療資源匱乏的農村地區進行遠距病理診斷。隨著醫院日益融入綜合醫療體系，對病理設備互通性和集中診斷的需求也日益成長。

哪些創新正在顛覆傳統的病理學工作流程？

數位轉型正在透過將成像、分析和雲端基礎設施整合到傳統工作流程中，重新定義病理學設備格局。能夠以 40 倍放大倍率擷取影像的全切片掃描器擴大配備了快速自動對焦、用於深度解析度的 Z 軸堆疊以及用於大樣本量的批量掃描功能。這些儀器與 AI/ML 演算法相輔相成，有助於量化組織特徵、標記潛在異常並產生自動診斷提案，簡化了病理學家的決策流程。

自動化是另一個關鍵的顛覆性因素。從自動化試劑和通訊協定選擇的智慧染色平台開始，病理實驗室正在最大限度地減少人工干預，降低週轉時間和錯誤率。模組化實驗室自動化系統現已將樣本追蹤、條碼讀取器、液體處理器和載玻片蓋片滑行器連接成一個無縫的診斷流程，使實驗室能夠在不影響診斷準確性的情況下實現更快的通量。與實驗室資訊系統 (LIS) 的整合進一步確保了即時追蹤、合規性和高效報告。

此外，伴隨診斷的興起也影響著設備的發展。製藥公司和診斷設備製造商正在合作建立病理學平台，以支援基於組織的生物標記檢驗，從而實現有針對性的標靶治療化腫瘤治療。多重免疫組化 (IHC) 和原位雜合反應(ISH) 工具正在幫助實驗室在單張玻片上檢測多種生物標記物，從而節省組織樣本並提高診斷產量。這些技術也正在根據 FDA 和 CE 標誌框架進行監管檢驗，以實現全球臨床部署。

哪些最終用戶和區域市場正在推動病理設備的需求？

病理設備的主要終端使用者是醫院、參考實驗室、學術醫療中心和癌症研究機構。大型連鎖醫院正在迅速採用自動化病理檢測平台，以應對日益成長的活體組織切片量、縮短報告時間並最佳化病理人力配置。為多家醫療機構處理檢測的中央實驗室正在加大對機器人技術和數位病理解決方案的投資，以提高效率並實現遠距會診。

學術機構和癌症中心在下一代設備的早期採用中發揮關鍵作用，尤其是涉及人工智慧解讀和多重免疫組織化學技術的設備。這些中心通常充當新興技術的檢驗中心，並為臨床和監管核准所需的依證做出貢獻。此外，製藥研發和委外研發機構(CRO) 正在採用數位病理學平台進行生物標記篩檢和藥物療效測試，從而推動臨床前市場的成長。

從區域層面來看，北美和西歐憑藉其先進的醫療基礎設施、較高的活體組織切片量以及對病理診斷的補貼性報銷政策，繼續保持領先地位。尤其是在美國，有利的醫療保險和醫療補助服務中心（CMS）政策和美國食品藥物管理局（FDA）的數位影像指南促進了病理實驗室的整合和數位病理學的廣泛應用。同時，以中國、印度和韓國為首的亞太地區，由於癌症篩檢計畫的不斷擴大以及公私合作診斷鏈的擴張，病理學基礎設施正在快速成長。拉丁美洲和中東是新興市場，對三級醫療和癌症診斷的投資正在為設備應用鋪平新的道路。

哪些因素推動了全球病理設備市場的成長？

全球病理學設備市場的成長動力源自於慢性病和腫瘤疾病的日益普及、對早期精準診斷的需求、數位病理學和實驗室自動化技術的進步，以及全球對個人化醫療的追求。癌症發生率的上升、人口老化以及預防保健意識的不斷增強，要求診斷系統能夠提供快速、可重複且可操作的結果，從而推動了對先進病理學設備的需求。

全球各地的醫療保健系統正在採用集中式數位化病理學平台，以解決訓練有素的病理學家短缺的問題，縮短從檢體到報告的時間，並提高診斷品質。同時，病理學與分子診斷和人工智慧分析的日益融合，使臨床醫生能夠從組織樣本中獲得更深入的洞察，為制定個人化治療方案鋪平道路。這些因素在腫瘤學中尤其重要，因為腫瘤學的治療效果通常取決於準確的腫瘤分類和生物標記狀態。

此外，來自醫療器材公司、創業投資和醫療IT公司的強勁投資正在加速創新和商業化。診斷實驗室、高科技公司和製藥公司之間的協同開發正在創造適用於下一代醫療保健的解決方案。監管方面的進步，例如數位病理設備的核准和靈活的臨床試驗要求，正在進一步消除進入障礙。隨著數位醫學和精準醫療的融合，病理設備已成為現代診斷技術的關鍵，推動全球市場強勁且持續的擴張。

部分

技術（臨床化學、免疫檢測、微生物學、分子診斷、其他技術）、應用（藥物發現和開發、疾病診斷、法醫學診斷、其他應用）、最終用戶（製藥公司、醫院和診斷實驗室、其他最終用戶）

受訪公司範例

3DHISTECH
Abbott Laboratories
Agilent Technologies
Beckman Coulter（Danaher）
Becton, Dickinson and Company（BD）
Bio-Rad Laboratories
CellaVision
ContextVision
Danaher Corporation
Epredia（3DHISTECH）
F. Hoffmann-La Roche AG
Hamamatsu Photonics
Hamamatsu Photonics
Leica Biosystems（Danaher）
Mikroscan Technologies
Olympus Corporation
Ortho-Clinical Diagnostics
PerkinElmer
PHC Holdings/Sakura Finetek
Philips（Digital Pathology）

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Pathology Devices estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Clinical Chemistry Technology, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.3% CAGR

The Pathology Devices market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Pathology Devices Market - Key Trends & Drivers Summarized

How Are Pathology Devices Advancing to Meet the Demands of Precision Diagnostics?

Pathology devices are at the forefront of the medical diagnostics ecosystem, serving as the backbone of disease detection, classification, and therapeutic monitoring. The shift toward precision medicine, minimally invasive diagnostics, and early disease identification is driving innovation across a range of pathology instrumentation, including histopathology equipment, cytology systems, immunohistochemistry platforms, digital pathology scanners, and automated slide processors. These tools play an indispensable role in enabling high-throughput, reproducible, and analytically sensitive laboratory workflows.

Histopathological examination remains the gold standard in cancer diagnostics and disease staging, making the demand for automated tissue processors, microtomes, embedding centers, and staining systems more critical than ever. Cytology devices, including liquid-based cytology (LBC) systems and automated slide preparers, are gaining traction in cancer screening programs, particularly for cervical and respiratory tract cancers. Immunohistochemistry (IHC), meanwhile, has seen significant adoption for biomarker detection in oncology, with antibody-based staining systems being integrated into lab automation chains for consistency and scalability.

Moreover, the advent of digital pathology is transforming slide-based diagnostics from analog to image-centric platforms. Whole-slide imaging (WSI) devices convert traditional glass slides into high-resolution digital formats, which are then analyzed via AI-powered software for cell morphology, tumor grading, and anomaly detection. This digital transition is enabling remote collaboration between pathologists, reducing inter-observer variability, and supporting telepathology for underserved and rural regions. As hospitals consolidate into integrated healthcare systems, the demand for pathology device interoperability and centralized diagnostics continues to rise.

What Technology Innovations Are Disrupting Traditional Pathology Workflows?

Digital transformation is redefining the pathology device landscape by integrating imaging, analytics, and cloud infrastructure into conventional workflows. Whole-slide scanners, capable of capturing images at 40x magnification, are increasingly equipped with high-speed autofocus, z-stacking for depth resolution, and batch scanning capabilities for large sample volumes. These devices are complemented by AI/ML algorithms that assist in quantifying tissue features, flagging potential abnormalities, and generating automated diagnostic suggestions-streamlining the pathologist’s decision-making process.

Automation is another key disruptor. From robotic arms used in sample accessioning to smart staining platforms that auto-select reagents and protocols, pathology labs are minimizing manual intervention to reduce turnaround time and error rates. Modular lab automation systems now link sample tracking, barcode readers, liquid handlers, and slide cover-slippers into a seamless diagnostic pipeline, allowing laboratories to achieve faster throughput without compromising diagnostic accuracy. Integration with Laboratory Information Systems (LIS) further ensures real-time tracking, compliance, and reporting efficiency.

Additionally, the rise of companion diagnostics is influencing device development. Pharmaceutical companies and diagnostics manufacturers are collaborating to build pathology platforms that support tissue-based biomarker validation, enabling targeted therapies and personalized oncology treatments. Multiplex IHC and in situ hybridization (ISH) tools are helping laboratories detect multiple biomarkers on a single slide, increasing diagnostic yield while conserving tissue samples. These technologies are also being validated for regulatory compliance under FDA and CE marking frameworks, making them viable for clinical deployment worldwide.

Which End-Use Settings and Regional Markets Are Driving Demand for Pathology Devices?

Hospitals, diagnostic reference laboratories, academic medical centers, and cancer research institutions represent the primary end-users of pathology devices. Large hospital chains are rapidly adopting automated pathology platforms to accommodate growing biopsy volumes, shorten reporting timelines, and optimize pathology manpower. Centralized labs that process tests for multiple healthcare providers are increasingly investing in robotic and digital pathology solutions to boost efficiency and enable remote consultations.

Academic institutions and cancer centers play a critical role in the early adoption of next-generation devices, particularly those involving AI interpretation and multiplex immunohistochemistry. These centers often serve as validation hubs for emerging technologies and contribute to the evidence base required for clinical and regulatory approvals. Additionally, pharmaceutical R&D and contract research organizations (CROs) are adopting digital pathology platforms for biomarker screening and drug efficacy trials-creating a growing non-clinical market for pathology devices.

Regionally, North America and Western Europe remain dominant due to advanced healthcare infrastructure, high biopsy volumes, and supportive reimbursement for pathology-based diagnostics. The U.S., in particular, is witnessing consolidation of pathology labs and strong uptake of digital pathology due to favorable CMS policies and FDA's digital imaging guidelines. Meanwhile, Asia-Pacific-led by China, India, and South Korea-is experiencing rapid growth in pathology infrastructure as cancer screening programs expand and public-private diagnostic chains scale up operations. Latin America and the Middle East are emerging markets where investments in tertiary care and cancer diagnosis are opening up new pathways for device adoption.

What Factors Are Driving the Growth of the Global Pathology Devices Market?

The growth in the global pathology devices market is driven by the increasing prevalence of chronic and oncological diseases, demand for early and accurate diagnostics, advancements in digital pathology and lab automation, and the global push toward personalized medicine. With rising cancer incidence, aging populations, and greater awareness about preventive health, there is growing pressure on diagnostic systems to deliver fast, reproducible, and actionable results-propelling the demand for advanced pathology devices.

Healthcare systems worldwide are adopting centralized and digitized pathology platforms to address shortages of trained pathologists, reduce sample-to-report time, and improve diagnostic quality. In parallel, the integration of pathology with molecular diagnostics and AI analytics is enabling clinicians to extract deeper insights from tissue samples, paving the way for personalized therapy plans. These factors are particularly relevant in oncology, where treatment efficacy often depends on precise tumor classification and biomarker status.

Furthermore, strong investments from medical device firms, venture capitalists, and healthcare IT companies are accelerating innovation and commercialization. Collaborations between diagnostic labs, tech companies, and pharma players are resulting in co-developed solutions tailored for next-generation healthcare. Regulatory advancements, such as digital pathology device approvals and flexible clinical trial requirements, are further removing entry barriers. As digital and precision medicine converge, pathology devices are set to become indispensable to modern diagnostics, driving strong and sustained global market expansion.

SCOPE OF STUDY:

The report analyzes the Pathology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology, Other Technologies); Application (Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application, Other Applications); End-User (Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

3DHISTECH
Abbott Laboratories
Agilent Technologies
Beckman Coulter (Danaher)
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories
CellaVision
ContextVision
Danaher Corporation
Epredia (3DHISTECH)
F. Hoffmann-La Roche AG
Hamamatsu Photonics
Hamamatsu Photonics
Leica Biosystems (Danaher)
Mikroscan Technologies
Olympus Corporation
Ortho-Clinical Diagnostics
PerkinElmer
PHC Holdings / Sakura Finetek
Philips (Digital Pathology)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Pathology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Global Cancer Burden Throws the Spotlight on Advanced Pathology Diagnostic Equipment
- Automation and Digital Pathology Trends Drive Demand for High-Throughput Devices
- Integration of Artificial Intelligence in Histopathology Spurs Workflow Efficiency and Accuracy
- Expansion of Precision Medicine and Molecular Diagnostics Strengthens Business Case for Pathology Platforms
- Increased Adoption of Digital Slide Scanners and Image Analysis Systems Propels Market Growth
- Growth in Biopsy Testing and Early Disease Detection Accelerates Use of Specialized Pathology Instruments
- Integration of LIS and EMR Systems Enhances Data Interoperability for Pathology Labs
- Global Shortage of Pathologists Promotes Use of AI-Driven Diagnostic Devices
- Demand for Remote Pathology and Telemedicine Platforms Expands Use of Digital Diagnostic Equipment
- Government Funding for Cancer Screening and Laboratory Modernization Supports Market Penetration
- Regulatory Approvals for AI-Based Diagnostic Algorithms Spur Commercialization of Smart Devices
- Advancements in Multi-Modality Imaging and Staining Technologies Enhance Device Functionality
- Rising Geriatric Population Drives Screening Volume for Age-Linked Diseases and Tumors
- Focus on Lab Efficiency and Turnaround Time Reductions Fuels High-Speed Device Adoption
- Increased Sample Volume in Oncology and Infectious Disease Diagnostics Boosts Equipment Demand
- Growth in Clinical Research and Biobank Development Expands Pathology Device Applications
- Emergence of Integrated Pathology Workstations Optimizes End-to-End Diagnostic Workflows
- Market Consolidation Among Device Manufacturers Spurs Innovation Through Strategic Acquisitions
- Customization and Scalability Requirements Propel Demand for Modular Pathology Systems
- Stringent Quality Control and Accreditation Norms Drive Adoption of Standardized Diagnostic Equipment
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Pathology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Pharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Hospitals & Diagnostic Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Forensic Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 46: USA 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 49: USA 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 55: Canada 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 58: Canada 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
JAPAN
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 64: Japan 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 67: Japan 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
CHINA
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 73: China 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 76: China 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
EUROPE
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 85: Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 88: Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
FRANCE
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 94: France 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 97: France 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
GERMANY
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 103: Germany 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 106: Germany 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 112: Italy 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 115: Italy 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 121: UK 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 124: UK 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
SPAIN
- TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 130: Spain 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 131: Spain Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 133: Spain 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 139: Russia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 140: Russia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 142: Russia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 148: Rest of Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 151: Rest of Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
AUSTRALIA
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 169: Australia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 170: Australia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 172: Australia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
INDIA
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 173: India Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 178: India 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 179: India Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 181: India 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 187: South Korea 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 188: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 190: South Korea 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
LATIN AMERICA
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 208: Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 211: Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 217: Argentina 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 218: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 220: Argentina 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 226: Brazil 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 227: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 229: Brazil 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
MEXICO
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 235: Mexico 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 236: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 238: Mexico 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
MIDDLE EAST
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 256: Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 259: Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
IRAN
- TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 265: Iran 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 266: Iran Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 268: Iran 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 274: Israel 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 275: Israel Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 277: Israel 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 292: UAE 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 293: UAE Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 295: UAE 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
AFRICA
- Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 310: Africa 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
- TABLE 311: Africa Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 313: Africa 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030